fda glp-1 safety warning september 2025 Alarming rise in weight loss drug overdoses Safe use of compounded GLP

Journalist, Sara Talpos, delves into the origin story of BPC-157, a story many will not have known

By product, the Tirzepatide segment is expected to grow at a CAGR of 12.87% during the forecast period

Survodutide and mazdutide represent other emerging options in this space

Se conocen como agonistas del receptor de GLP-1 e incluyen marcas como Ozempic, Wegovy y Mounjaro

Patients should be advised to: Eat smaller, more frequent meals rather than large portions Avoid high-fat, greasy, or spicy foods that delay gastric emptying further Stop eating when comfortably satisfied rather than feeling full Stay well-hydrated with small, frequent sips of water throughout the day Avoid lying down immediately after eating Limit alcohol consumption, which can irritate the stomach lining Timing of medication administration may also help, though evidence for this is limited with weekly injections